Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in EBS — Emergent BioSolutions Inc.

CIK 72971 SAN FRANCISCO, CA
Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$422,266
+$174,406 QoQ
Shares Held
50,390
+68.7% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 194 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. EBS ranks #34 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,809,278 $130,014,715
2 HLN
Haleon plc
 4,924,330 $45,943,997
3 NBIX
Neurocrine Biosciences Inc
 253,026 $42,644,999
4 UTHR
UNITED THERAPEUTICS Corp
 74,303 $40,259,592
5 ELAN
Elanco Animal Health Inc
 976,361 $24,028,242
6 HIMS
Hims & Hers Health, Inc.
 559,389 $19,394,014
7 VTRS
Viatris Inc
 1,175,495 $18,666,859
8 TAK
Takeda Pharmaceutical Co Ltd
 1,150,820 $18,447,643

All Filings in EBS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $422,266 50,390
2026-03-31 $247,860 29,863
2025-12-31 $855,446 69,211
2025-09-30 $459,556 52,104
2025-06-30 $291,507 45,691
2025-03-31 $53,828 11,076
2024-12-31 $79,797 8,347
2024-09-30 $167,099 20,012
2024-06-30 $24,107 3,535
2024-03-31 $56,433 22,306
2023-12-31 $47,519 19,800
2023-09-30 $59,057 17,370
2023-06-30 $938,115 127,635
2023-03-31 $936,274 90,374
2022-12-31 $223,669 18,939
2022-09-30 $224,317 10,687
2022-06-30 $5,450,931 175,610
2022-03-31 $11,872,496 289,150
2021-12-31 $13,729,215 315,832
2021-09-30 $20,886,749 417,151
2021-06-30 $18,333,741 291,058
2021-03-31 $42,882,794 461,552
2020-12-31 $39,719,408 443,297
2020-09-30 $62,794,774 607,711
2020-06-30 $36,942,457 467,153
2020-03-31 $27,149,473 469,227